Intermittent positive-pressure breathing. A critical appraisal.
There are relatively few valid indications for the use of intermittent positive-pressure breathing (IPPB). It is of limited or no value as prophylaxis of postoperative pulmonary problems (pneumonia, atelectasis) or as a means of delivering aerosol medications or treating stable chronic obstructive pulmonary disease. In these situations, IPPB has few if any advantages over voluntary hyperventilation or deep breathing.
D000336:Aerosols; D002908:Chronic Disease; D003365:Costs and Cost Analysis; D006801:Humans; D007384:Intermittent Positive-Pressure Breathing / Q000009:adverse effects / Q000706:statistics & numerical data; D008171:Lung Diseases / Q000517:prevention & control; D008173:Lung Diseases, Obstructive / Q000628:therapy; D011175:Positive-Pressure Respiration / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000517:prevention & control; D012119:Respiration; D014481:United States
D000336:Aerosols